Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage

Eur J Ophthalmol. 2024 Jan;34(1):NP96-NP99. doi: 10.1177/11206721231178058. Epub 2023 May 30.

Abstract

Background: Anterior Chamber bleeding without vitreous hemorrhage had been described after the removal of 23G vitrectomy cannulas. We report the case of an anterior chamber bleeding after an intravitreal Dexamethasone implant.

Case report: One patient with macular edema due to central retinal vein occlusion in a vitrectomized eye underwent an intravitreal Dexamethasone implant. After the injection the patient suffered from anterior chamber bleeding without signs of vitreous hemorrhage. The complication resolved with a conservative treatment.

Conclusion: Anterior Chamber bleeding is a possible complication of dexamethasone implant, that can be treated in a conservative way.

Keywords: CME; postoperative anterior segment problems; retina - medical therapies; retinal breaks; venous occlusive disease.

Publication types

  • Case Reports

MeSH terms

  • Anterior Chamber
  • Dexamethasone* / adverse effects
  • Drug Implants / adverse effects
  • Glucocorticoids / adverse effects
  • Humans
  • Intravitreal Injections
  • Retinal Vein Occlusion* / complications
  • Retinal Vein Occlusion* / diagnosis
  • Retinal Vein Occlusion* / drug therapy
  • Vitreous Hemorrhage / complications
  • Vitreous Hemorrhage / etiology

Substances

  • Dexamethasone
  • Glucocorticoids
  • Drug Implants